Fujifilm, Dr Reddy's terminate generics JV
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...Read more
Takeda makes massive changes in its organization
Japan | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a ne...Read more
Taiho to start ph III trial in colorectal cancer
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 May, 2012
Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...Read more
Oramed gets Japanese patent for protein delivery
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2013
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by...Read more
LG to co-develop biosimilars with Mochida
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2012
Singapore: LG Life Sciences (LGLS) and Mochida Pharmaceutical have finalized the agreement to collaborate during the c...Read more
Challenges that Japan pharma will face in 2014
Japan | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013
Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situ...Read more
Fujitsu brings medical data to smartphones, iPad
Japan | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: The new mobile integrated EMR technology, developed by Fujitsu, a Japanese multinational information technolo...Read more
Chugai expands in Singapore with research institute
Japan | News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2012
Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...Read more
Eisai US to replace its president, CEO
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2014
Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive offi...Read more
François-Xavier Roge is Takeda's new CFO
Japan | Influencers | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2013
Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...Read more
Eisai seeks nod for cancer, epilepsy drug in S Africa
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (peramp...Read more
Otsuka schizophrenia drug seeks EMA nod
Japan | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Dec, 2012
Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the app...Read more
Santen to give $7.9 mn fund to Clearside
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announced...Read more
Takeda partners with Wipro for IT solutions
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 May, 2014
Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Tak...Read more
Affymax, Takeda recall anemia drug Omontys
Japan | News | By BioSpectrum Bureau | 0 Comment | 25 Feb, 2013
Singapore: Affymax and Takeda Pharma decided to voluntarily recall all lots of Omontys (peginesatide) injection to the u...Read more
Astellas completes patient recruitment in drug trial
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...Read more
EMA accepts market authorization plea for alogliptin
Japan | News | By BioSpectrum Bureau | 0 Comment | 25 May, 2012
Singapore: The European Medicines Agency has accepted a marketing authorization application for alogliptin, a selective ...Read more
Daiichi Sankyo expands drug discovery program
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...Read more